Is there a personalized medicine for mood disorders?

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Current Major Depressive Disorder (MDD) diagnosis relies on behavioral criteria with modest biological correlation.
• Peripheral biomarker research for MDD diagnostics and treatment response has yielded limited clinical success.
• Neuroimaging genetics has identified intermediate imaging phenotypes for MDD and treatment response.

Purpose of the Study:

• To propose utilizing intermediate phenotypes from imaging genetics studies as surrogates for behavioral assessments in biomarker research.
• To explore the potential of these intermediate phenotypes in the search for accessible peripheral biomarkers for MDD.
• To review the current landscape of peripheral and neural biomarker research in MDD.

Main Methods:

• Review of existing literature on peripheral biomarkers for MDD.
• Analysis of findings from imaging genetics studies related to MDD and treatment response.
• Conceptual framework for using intermediate imaging phenotypes in biomarker discovery.

Main Results:

• Behavioral criteria for MDD and treatment response show limited correlation with biological measures.
• Imaging genetics offers intermediate phenotypes linked to MDD neurobiology, but not yet for broad clinical use.
• The proposed strategy aims to bridge the gap between complex neural measures and accessible peripheral biomarkers.

Conclusions:

• Intermediate phenotypes from imaging genetics are promising substitutes for behavioral diagnoses in biomarker research.
• This approach could accelerate the development of reliable peripheral biomarkers for MDD.
• Further research integrating neuroimaging genetics with peripheral biomarker discovery is warranted.